Cited by 448Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Metformin Action: Concentrations Matter

Open access

He, Ling, Wondisford, Fredric E.·2015·Cell Metabolism

DOI 10.1016/j.cmet.2015.01.003

Open this paper in CoChat — free account Open PDF

Abstract

Metformin has been used for nearly a century and is now the most widely prescribed oral anti-diabetic agent worldwide. Yet how metformin acts remains only partially understood and controversial. One key reason may be that almost all previous studies were conducted with supra-pharmacological concentrations (doses) of metformin, 10-100 times higher than maximally achievable therapeutic concentrations found in patients with type 2 diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2015.01.003

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Metformin Inhibits Hepatic Gluconeogenesis in Mice Independently of the LKB1/AMPK Pathway via a Decrease in Hepatic Energy State
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 845
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495

Show all 18 references

Sorted by citations

Items 401–448 of 448

The enhancement of CRISPR/Cas9 gene editing using metformin
Rollins, J. L., Hall, R. M., Lemus, C. J., Leisten, L. A., & Johnston, J. M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101539
Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Kabir, M. I., Kumar, R., Bugata, L. S. P., & Raina, K. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00336-w
Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2iPreprint
Adam, J., Harada, M., Covic, M., Brandmaier, S., Muschet, C., Huang, J., Han, S., Ge, J., Rommel, M., Rotter, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3931333/v1
مقارنة تأثير المستخلص المائي لثمار نبات البامية Abelmoschus Esculentus مع عقار الميتفورمين على إناث الجرذان المصابة بالسكري
أدريس, ع., عزاقة, إ., & عبدالله, ف. (2024) · Journal of Pure & Applied Sciences · doi:10.51984/jopas.v23i1.2389
Pathogenetic basis of treating endothelial dysfunction with metformin in patients with diabetes (literature review and own data)
Sokolova, A. M., PUSHKAREV, V. V., SOKOLOVA, L. K., Pushkarev, V. M., & Tronko, M. D. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.3.2024.1391
The value of a negative study
Williams, K. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118530
Bacterial targets of fecal host miRNAs in high-fat diet-fed mice
Silamiķele, L., Silamiķelis, I., Kotoviča, P. P., & Kloviņš, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315871
Heightened sensitivity to adverse effects of metformin in mtDNA mutant patient cells
Ryytty, S., Nurminen, K., Mäkinen, P. I., Suomalainen, A., & Hämäläinen, R. H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123486
Metformin-Induced Mitochondrial Remodeling Creates Adaptive and Targetable Vulnerabilities in Cancer CellsPreprint
Bhati, F. K., Saha, U., Singh, S., & Bhat, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656565
Effect of metformin on spontaneous calcium signaling in cultured astrocytes during normoxic and hypoxic conditions
Svirskienė, N., Svirskis, G., Jankevičiūtė, S., & Borutaitė, V. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110494
Reframing metformin as a gut-targeted glucose-lowering therapy: Mechanistic insights and translational relevance
Wu, T., Horowitz, M., Jones, K. L., & Rayner, C. K. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102276
Integration of artificial intelligence and high-content screening enabled identification of drugs for long-term treatment of cerebral cavernous malformation diseasePreprint
Frías-Anaya, E., Gallego-Gutiérrez, H., Bui, C., Birrueta, J. O., Steinberg, J. D., Niesman, I. R., Gongol, B., Nguyen, B., Sawhney, A., Mizushima, Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.08.693036 · Cited by 1
Additional file 2 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588644
Additional file 14 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588632
Additional file 3 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329581
Additional file 1 of Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening
Luo, Z., Wang, B., Luo, F., Guo, Y., Jiang, N., Wei, J., Wang, X., Tseng, Y., Chen, J., Zhao, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24089216
Additional file 1 of STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
Pěnčík, J., Philippe, C., Schlederer, M., Atas, E., Pecoraro, M., Grund‐Gröschke, S., Li, W., Tracz, A., Heidegger, I., Lagger, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23937289
Additional file 10 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588620
Additional file 13 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588629
Additional file 1 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588641
Additional file 12 of Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones
Karademir, D., Todorova, V., Ebner, L. J. A., Samardzija, M., & Grimm, C. (2022) · Figshare · doi:10.6084/m9.figshare.19588626
Additional file 1 of Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin
Šimčíková, D., Gardáš, D., Hložková, K., Hruda, M., Žáček, P., Rob, L., & Heneberg, P. (2021) · Figshare · doi:10.6084/m9.figshare.17163368
Additional file 1 of Akkermansia muciniphila, which is enriched in the gut microbiota by metformin, improves cognitive function in aged mice by reducing the proinflammatory cytokine interleukin-6
Zhu, X., Shen, J., Feng, S., Huang, C., Wang, H., Huo, F., & Liu, H. (2023) · Figshare · doi:10.6084/m9.figshare.23265023
Additional file 2 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329578
Additional file 2 of Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening
Luo, Z., Wang, B., Luo, F., Guo, Y., Jiang, N., Wei, J., Wang, X., Tseng, Y., Chen, J., Zhao, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24089219
Additional file 1 of Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i
Harada, M., Adam, J., Covic, M., Ge, J., Brandmaier, S., Muschet, C., Huang, J., Han, S., Rommel, M., Rotter, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26027587
Additional file 1 of Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Zhang, Y.-L., Liu, F., Li, Z.-B., He, X.-T., Li, X., Wu, R.-X., Sun, H.-H., Ge, S.-H., Chen, F.-M., & An, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329575
Additional file 1 of Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
Singh, A., Gu, J. J., Zhang, Q., Torka, P., Sundaram, S., Mavis, C. K., & Hernandez‐Ilizaliturri, F. J. (2020) · Figshare · doi:10.6084/m9.figshare.12612613
Relationship between breast cancer and metformin: A bibliometric review
Wang, Z., Zhao, F., & Wang, L. (2026) · Medicine · doi:10.1097/md.0000000000047868
Abolishing respiratory complex I decreases in vivo growth of high grade serous ovarian cancer cells and sensitizes to anti-angiogenic therapyPreprint
Kurelac, I., Cavina, B., Nanetti, F., Corra, S., Sollazzo, M., Coadǎ, C. A., Grillini, M., Scalambra, L., Lama, E., Angi, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.708681
Antidiabetic pharmacotherapy aiding in fertility restoration: an integrative review of current evidence
Koshy, R. R., Kumar, A. A., Maliyil, B. T., Regie, R., Jairaj, S., & Satish, M. T. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00316-2
Metformin & Chronic Kidney Disease (CKD) : a reassessment of the benefit/risk ratio
Kajbaf, F. (2015) · theses.fr (ABES) · doi:10.70675/7a26b581z94ddz4e2fz9a48z97f6f7d8354a
Effet de la metformine sur la production des formes réactives de l'oxygène par les macrophages M2 humains et les cellules épithéliales intestinales cancéreuses HCT116
Nassif, R. (2021) · theses.fr (ABES) · doi:10.70675/25eb5ad3za8e9z4ef0zaf50ze761f2fc5884
Predicting stress-induced vulnerability to depression in diabetes
Alaeddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/41d9cd78zd5dez4ccfzae36zbb176db78e3f
Development of metformin-encapsulated poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles
İtil, E., Surer, S. I., Hızlıateş̨, C. G., & Oktay, G. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12042-z
Metformin as adjuvant in standard therapy in patients with diffuse large B-cell lymphoma: A systematic review and meta-analysis
Ramadhan, M. B., Hakim, M. H., Suskhan, M. N., & Cahyanur, R. (2026) · South Asian Journal of Cancer · doi:10.25259/sajc_11_2025
Dissociation between metabolic and neurobehavioral effects of metformin in a model of chronic fructose consumption in female mice
Szeremeta, Y. C., Barros, W. D. M., Dezanetti, T., de Oliveira, V. E., Amaral, P. A. H., Ferreira, J. B., Cunha, M. P., Guiard, B. P., & Moreira, E. L. G. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100510
AMPK‐mediated prevention of vascular dysfunction with metformin: Experimental and population‐based evidence
Jouabadi, S. M., Jüttner, A. A., Claringbould, A., VRIES, R. D., Garrelds, I. M., Musterd‐Bhaggoe, U. M., Stricker, B. H. C., Kavousi, M., Danser, A. H. J., Ahmadizar, F., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70533 · Cited by 1
Antidiabetic medications and the risk of bladder cancer in patients with diabetes mellitus: A systematic review and meta-analysis
Lei, D., Wu, J.-H., Zeng, X.-H., Xu, R., Zheng, S.-S., Zhu, X.-J., & Jian-a, Y. (2026) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2026.05.024
Metformin Partially Attenuates Simvastatin‐Induced Myotoxic Responses in C2C12 Myotubes Through Metabolic Adaptation
He, C., Wesselink, M., Huijts, J. Y., Zhong, Z., Eggelbusch, M., Jaspers, R. T., & Wüst, R. C. I. (2026) · The FASEB Journal · doi:10.1096/fj.202600077rrr
НЕЙРОПРОТЕКТОРНЫЕ ФУНКЦИИ МЕТФОРМИНА (ОБЗОР ЛИТЕРАТУРЫ)
Гридасова, Е. И., Плешкова, В. С., Чичкан, А. С., & Смирнова, П. Н. (2026) · Military and tactical medicine Emergency medicine · doi:10.55359/2782-3296.2026.81.44.009
Metformin triggers ATF4-mediated UPRmt and COX-2 inflammation in adipocytes
Poothong, J., Chiamkunakorn, C., Suthammarak, W., Phanaksri, T., Auewarakul, P., Yong, J., & Kaufman, R. J. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120191
The coordinated actions of metformin in the intestine and liver improves hyperglycemia
He, L., An, H., Ramirez, K., Radovick, S., & Wondisford, F. E. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117791 · Cited by 1
Mitochondrial metabolic remodelling during bacterial infection: Molecular mechanisms, cellular consequences, and therapeutic opportunities
Kowalik, A., Paszenda, P., Frątczak, A., Piwowar, A., Obrycka, P., Dudek, M., & Woźniak, S. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103873
Repurposed metformin–apigenin combination therapy for metabolic dysfunction-associated steatohepatitis: from integrative multi-omics discovery to in vivo validation
Zhang, K., Chen, Y., Ran, L., Tong, W., Dai, L., Yang, Z., Chen, Q., Zheng, J., & Hu, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1857676
Metformin Attenuates the High-Glucose Effect on MORG1 Expression in HEK293 Cells
Bondeva, T., Reuter, S., Westphal, A., Mrowka, R., & Wolf, G. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090934
Mitochondrial Dynamics in Diabetes Mellitus and Its Complications: Mechanisms, Pathological Roles, and Therapeutic Implications
Wang, G., Zhao, Y., Liu, G., Du, Y., Liu, S., Yang, Y., Bu, S., & Zhao, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198451
Metformin Inhibits Ferroptotic Cell Death by Suppressing Cysteine Deprivation‐Induced Mitochondrial Dysfunction
Jang, S., Kim, S., Kim, G., Hong, J., Park, I., & Jin, H. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70330

Authors: He, L., & Wondisford, F. E.
Affiliations: Johns Hopkins University (US)
Corresponding author: Wondisford, Fredric E.
ORCID: He, Ling
Wondisford, Fredric E.
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2015-02
Volume: 21
Issue: 2
Pages: 159-162
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2015.01.003
OpenAlex: W2080654617
Cited by: 448
References: 18
Citations by year: 2026: 25 · 2025: 30 · 2024: 39 · 2023: 43 · 2022: 61 · 2021: 57 · 2020: 59 · 2019: 37 · 2018: 41 · 2017: 30 · 2016: 16 · 2015: 10
FWCI: 14.05
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 367 d)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords: metformin, type 2 diabetes, mechanism of action, therapeutic drug concentrations, oral antidiabetic drugs, pharmacokinetics
MeSH terms: Animals, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Humans, Metformin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin Action: Concentrations Matter

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks